Home › Small Cell Lung Cancer › Illinois › Chicago

Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Chicago, IL

Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Nagre-recruitPhase 3

University of Chicago Medical Center /ID# 280149, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07365241

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Northwestern University Feinberg School of Medicine, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Nagre-recruitPhase 1/2

University of Chicago ( Site 1108), Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06780137

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Nagre-recruitPhase 2

Northwestern, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07057791

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Nagre-recruitPhase 3

Rush MD Anderson Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06203210

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Nagre-recruitPhase 1

University of Illinois Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06598306

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Nagre-recruitPhase 2

University of Illinois Chicago, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT07149363

A Study of LY4175408 in Participants With Advanced Cancer

Nagre-recruitPhase 1

The University of Chicago Medical Center (UCMC), Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Nagre-recruitPhase 2

University of Illinois Cancer Center, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 8, 2026 · NCT04919382

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

Nagre-recruitPhase 2

Northwestern University, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT06769126

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Nagre-recruitPhase 1/2

Jesse Brown VA Medical Center, Chicago, IL, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT06681220

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Nagre-recruitPhase 2

University of Chicago Medicine, Chicago

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT05068232

Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Chicago

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.